Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Final height in isolated GH deficiency type 1A: effects of 5-year treatment with IGF-I.

European journal of endocrinology - 1 Apr 2001

Messina M F, De Luca F, Wasniewska M, Valenzise M, Lombardo F, Ghizzoni L

Abstract excerpt

Data concerning final height (FH) in isolated growth hormone deficiency type 1A (IGHD1A) are scanty and controversial. In this paper we report the FH outcome of two girls with IGHD1A who were treated either with GH only (first patient) or with GH during the first 8 years and successively with IGF-I (second patient). In the first patient, FH was only slightly subnormal and slightly taller with respect to target...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Height
Share to Child
Share to DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Human Growth Hormone

Share to Insulin-Like Growth Factor I

Share to Mutation

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Sexual Maturation

Source

Identifiers

PMID: 11275947
DOI: 10.1530/eje.0.1440379

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Final height in isolated GH deficiency type 1A: effects of 5-year treatment with IGF-I.PMID 11275947Read ↗

Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).Semantic proximity Read ↗

Phenotypic analysis and growth response to different growth hormone treatment schedules in two siblings with an inactivating mutation in the growth hormone-releasing hormone receptor gene.Semantic proximity Read ↗

Insulin-like growth factor 1 (IGF-1): a growth hormoneSemantic proximity Read ↗

Long-Term Treatment with Recombinant Insulin-Like Growth Factor (IGF)-I in Children with Severe IGF-I Deficiency due to Growth Hormone InsensitivitySemantic proximity Read ↗

Evaluation and phenotypic characteristics of 293 Danish girls with tall stature: effects of oral administration of natural 17β-estradiol.Semantic proximity Read ↗

GH therapy in Noonan syndrome: Review of final height data.Semantic proximity Read ↗

GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome).Semantic proximity Read ↗

Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.Semantic proximity Read ↗

Different Growth Responses to Recombinant Human Growth Hormone in Three Siblings with Isolated Growth Hormone Deficiency Type 1A due to a 6.7Kb Deletion in the GH1 GeneSemantic proximity Read ↗

Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency.Semantic proximity Read ↗

Final height and predicted height in boys with untreated constitutional growth delay.Semantic proximity Read ↗

Growth hormone deficiency in one of two siblings with Fanconi's anaemia complementation group FA-D.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.